DDF Latest News


Device Development Stream to be Extended for a Third Day in 2019

In 2018, the DDF Summit included a dedicated Device Development stream for the first time.
As combination products are on the rise and drug developers are increasingly taking ...

13 DDF 2018 Commercial Partners to Sponsor 2019 Event

2018 saw over 50 commercial partners join the DDF Summit to expand their reach in the drug
delivery and formulation community. We’re delighted to announce that over 94% ...

Official 2018 Highlights Video Released

There were 420 registered industry professionals for DDF Summit 2018, making it the biggest ever DDF event.
The conference has doubled in size since 2015 ...

OFFICIAL SUMMIT APP NOW READY TO DOWNLOAD

The official summit app is now ready to download and explore for all DDF Summit attendees.
The app is a great way to interact with all aspects of the summit. You can...

Meet EnableInjections, a DDF Summit sponsor

Enable Injections is a late-stage startup company that has developed the enFuse™ wearable platform, a disposable wearable infuser that delivers high volume (up to 50 ml), high viscosity drug/biological products to the subcutaneous tissue...

Poster Competition

The DDF Summit is all about showcasing the pioneering work pushing pharmaceutical development forward. Alongside the agenda sessions, the Poster Competition is an opportunity to display and discuss the promising ideas and results and could be tomorrow’s keynotes...

New Session: ‘DPI Products: From Small to Industrial Scale at Chiesi’

Isabel will be joining the Global DDF Summit to present a session entitled ‘DPI Products: From Small to Industrial Scale at Chiesi’. The goal of her presentation is to guide you around some of the processes associated to the development of a Dry Powder Inhaler (DPI) product ...

New Session: ‘Predictive Tools for Rational Development of Dry Powder Inhalation (DPI) Products and Process’

Amrit will present a session called ‘Predictive Tools for Rational Development of Dry Powder Inhalation (DPI) Products and Process’. This will discuss designing and manufacturing micro particles with delivery methods in mind ...

New Session: ‘The Power of Predictive Stability Modelling in Drug Product Development’

Ellen’s session will be named ‘The Power of Predictive Stability Modelling in Drug Product Development’. Ellen’s session will provide an introduction to risk-based predictive stability modelling to enable fast and better product understanding...

New Session: ‘Suspendilicious: Unveiling the Marvels of Lipid Suspensions’

The title of Kristof’s presentation is ‘Suspendilicious: Unveiling the Marvels of Lipid Suspensions’.It will discuss on the pre-clinical oral dosing of suspensions of solid dispersions and the pre-clinical oral dosing of suspensions of salts of very weak bases...

DDF Awarded ‘Best Conference’ at PPA Connect Awards

At the PPA Connect Awards 2017, the Global Drug Delivery and Formulation Summit took home the ‘Best Conference’ award! The PPA Connect Awards exist to reward and recognise the brilliant events being created in the business media and consumer magazine sector. The judges were looking for a conference that pushes the envelope and delivers high levels of satisfaction for attendees and partners. They assessed the event on feedback and value provided to the market...

New Recorded Presentations Available from DDF 2017

Two more recorded presentations from the Global Drug Delivery & Formulation Summit in 2017 have been uploaded to our Content Zone...

New Speakers Announced

Two pharmaceutical professionals from Sanofi and Janssen Pharmaceutica have joined the DDF programme for 2018...

Visit the Brand-New DDF LinkedIn Showcase Page

For the latest updates on the DDF Summit, follow the brand-new Showcase Page.
On this page you'll find summit news, videos and photos, new session announcements and exciting, summit-specific online content.
Visit us on LinkedIn.

New Session Added: Tissue Specific Delivery Using Caveolae Technology Improves Drug Efficacy

Ruchi Gupta (Scientist I) from MedImmune joins the brand-new Device Development stream to talk about the current bio-therapeutics focus on the molecular targets expressed on cells/tumors...

Welcome back to Adare Pharmaceuticals

Adare is a high-growth company with a long history of success from concept through commercialization. Our ability to create differentiated drugs guides the identification and development of the novel products in our pipeline and our acquisition strategy...

Check out Dr Dave Elder’s full recorded presentation from DDF Berlin 2017

The full presentation: Excipients and their Effects on the Quality of Small Molecules is now available to watch via the DDF Summit Content Zone...

Commercial Partners: